TY - JOUR
T1 - Lipopolysaccharide activates nuclear factor kB in rat intestine
T2 - Role of endogenous platelet-activating factor and tumour necrosis factor
AU - De Plaen, Isabelle G.
AU - Tan, Xiaodi
AU - Chang, Hong
AU - Wang, Liya
AU - Remick, Daniel G.
AU - Hsueh, Wei
PY - 2000
Y1 - 2000
N2 - 1. We examined the effect of lipopolysaccharide (LPS), a cell wall constituent of Gram negative bacteria, on nuclear factor kB (NF-kB) activation in the intestine and the roles of endogenous platelet-activating factor (PAF), tumour necrosis factor-A (TNF) and neutrophils. We also compared the time course of NF-kB activation in response to PAF and LPS. 2. Ileal nuclear extracts from LPS (8 mg kg-1, IV)-injected rats were assayed for NF-kB-DNA-binding activity and identification of the subunits. Some rats were pretreated with WEB2170 (a PAF receptor antagonist), anti-TNF antibody, or anti-neutrophil antiserum. NF-kB p65 was localized by immunohistochemistry. An additional group was challenged with PAF (2 mg kg-1, IV) for comparison. 3. LPS activates intestinal NF-kB, both as p50-p50 and p50-p65 dimers within 15 min, and the effect peaks at 2 h. The effect is slower and more sustained than that of PAF, which peaks at 30 min. Activated NF-kB was immunolocalized within epithelial and lamina propria cells. LPS effect was reduced by 41, 37 and 44, respectively, in animals pretreated with WEB2170, anti-TNF antibody, or anti-neutrophil antiserum (P < 0.05). 4. LPS activates intestinal NF-kB in vivo and neutrophil activation is involved in its action. The LPS effect is mediated by both endogenous PAF and TNF.
AB - 1. We examined the effect of lipopolysaccharide (LPS), a cell wall constituent of Gram negative bacteria, on nuclear factor kB (NF-kB) activation in the intestine and the roles of endogenous platelet-activating factor (PAF), tumour necrosis factor-A (TNF) and neutrophils. We also compared the time course of NF-kB activation in response to PAF and LPS. 2. Ileal nuclear extracts from LPS (8 mg kg-1, IV)-injected rats were assayed for NF-kB-DNA-binding activity and identification of the subunits. Some rats were pretreated with WEB2170 (a PAF receptor antagonist), anti-TNF antibody, or anti-neutrophil antiserum. NF-kB p65 was localized by immunohistochemistry. An additional group was challenged with PAF (2 mg kg-1, IV) for comparison. 3. LPS activates intestinal NF-kB, both as p50-p50 and p50-p65 dimers within 15 min, and the effect peaks at 2 h. The effect is slower and more sustained than that of PAF, which peaks at 30 min. Activated NF-kB was immunolocalized within epithelial and lamina propria cells. LPS effect was reduced by 41, 37 and 44, respectively, in animals pretreated with WEB2170, anti-TNF antibody, or anti-neutrophil antiserum (P < 0.05). 4. LPS activates intestinal NF-kB in vivo and neutrophil activation is involved in its action. The LPS effect is mediated by both endogenous PAF and TNF.
KW - In vivo
KW - Inflammation
KW - Lipopolysaccharide
KW - Transcription factors
UR - http://www.scopus.com/inward/record.url?scp=0033979832&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033979832&partnerID=8YFLogxK
U2 - 10.1038/sj.bjp.0703055
DO - 10.1038/sj.bjp.0703055
M3 - Article
C2 - 10694237
AN - SCOPUS:0033979832
SN - 0007-1188
VL - 129
SP - 307
EP - 314
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 2
ER -